Patents by Inventor Paul Sheard

Paul Sheard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10489787
    Abstract: An embodiment includes a method of multi-leg transaction processing. The method includes receiving from a merchant server, a designation of two or more sub-transactions of a pending multi-leg transaction as a coupled group. The execution of any of the two or more sub-transactions in the coupled group is dependent on prior authorization of each of the two or more sub-transactions. The method includes receiving transaction input used to indicate conditional execution of the multi-leg transaction. Prior to execution of the multi-leg transaction and in substantially real time, the method includes determining whether each of the two or more sub-transactions in the coupled group is authorized. In response to any of the two or more sub-transactions being unauthorized, the method includes preventing execution of the multi-leg transaction. In response to authorization of each of the two or more sub-transactions, the method includes executing the multi-leg transaction non-sequentially.
    Type: Grant
    Filed: December 30, 2015
    Date of Patent: November 26, 2019
    Assignee: PAYPAL, INC.
    Inventors: Paul Sheard, Kiran Kumar Sridhar, Mitendra Mahto
  • Publication number: 20170193512
    Abstract: An embodiment includes a method of multi-leg transaction processing. The method includes receiving from a merchant server, a designation of two or more sub-transactions of a pending multi-leg transaction as a coupled group. The execution of any of the two or more sub-transactions in the coupled group is dependent on prior authorization of each of the two or more sub-transactions. The method includes receiving transaction input used to indicate conditional execution of the multi-leg transaction. Prior to execution of the multi-leg transaction and in substantially real time, the method includes determining whether each of the two or more sub-transactions in the coupled group is authorized. In response to any of the two or more sub-transactions being unauthorized, the method includes preventing execution of the multi-leg transaction. In response to authorization of each of the two or more sub-transactions, the method includes executing the multi-leg transaction non-sequentially.
    Type: Application
    Filed: December 30, 2015
    Publication date: July 6, 2017
    Inventors: Paul Sheard, Kiran Kumar Sridhar, Mitendra Mahto
  • Patent number: 9689866
    Abstract: A device for remote management of patients suffering from heart failure and hypertension can measure one or more biomarker. The device aids in monitoring the efficacy and safety of treatment in such patients.
    Type: Grant
    Filed: January 29, 2013
    Date of Patent: June 27, 2017
    Assignee: INVERNESS MEDICAL SWITZERLAND GMBH
    Inventors: Paul Sheard, Marika Reay
  • Patent number: 8361389
    Abstract: A device for remote management of patients suffering from heart failure and hypertension can measure one or more biomarker. The device aids in monitoring the efficacy and safety of treatment in such patients.
    Type: Grant
    Filed: November 22, 2011
    Date of Patent: January 29, 2013
    Assignee: Inverness Medical Switzerland GmbH
    Inventors: Paul Sheard, Marika Reay
  • Publication number: 20120064613
    Abstract: A device for remote management of patients suffering from heart failure and hypertension can measure one or more biomarker. The device aids in monitoring the efficacy and safety of treatment in such patients.
    Type: Application
    Filed: November 22, 2011
    Publication date: March 15, 2012
    Inventors: Paul Sheard, Marika Reay
  • Patent number: 8129191
    Abstract: A device for remote management of patients suffering from heart failure and hypertension can measure one or more biomarker. The device aids in monitoring the efficacy and safety of treatment in such patients.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: March 6, 2012
    Assignee: Inverness Medical Switzerland GmbH
    Inventors: Paul Sheard, Marika Reay
  • Publication number: 20090226898
    Abstract: Damage to tissue, such as ischemic damage, can cause the release of mitochondrial markers. The released markers can be detected in a sample taken from a subject, indicating that the subject has suffered damage.
    Type: Application
    Filed: July 13, 2006
    Publication date: September 10, 2009
    Applicant: Inverness Medical Switzerland GMBH
    Inventor: Paul Sheard
  • Publication number: 20090081714
    Abstract: Methods and assays for monitoring the cardiac health of a subject are provided. The method involves the detection of a urotensin surrogate in a sample leading to a more accurate and reliable diagnosis of early or late stages of decompensated heart failure, heart failure, risk of a heart failur in a subject than the measurement of the cyclic peptide of urotensin alone.
    Type: Application
    Filed: July 10, 2006
    Publication date: March 26, 2009
    Applicant: Inverness Medical Switzerland GMBH
    Inventors: Leong Ng, Sarah Johnson, Steve Eida, Paul Sheard
  • Publication number: 20060063199
    Abstract: An inflammatory peptide can be a marker for cardiac ischemia.
    Type: Application
    Filed: November 23, 2004
    Publication date: March 23, 2006
    Inventors: Salwa Elgebaly, Paul Sheard
  • Publication number: 20050137481
    Abstract: A device for remote management of patients suffering from heart failure and hypertension can measure one or more biomarker. The device aids in monitoring the efficacy and safety of treatment in such patients.
    Type: Application
    Filed: December 17, 2004
    Publication date: June 23, 2005
    Inventors: Paul Sheard, Marika Reay
  • Patent number: 5387511
    Abstract: Enhanced extraction of solubilized antigens is obtained from bacteria such as Chlamydia and Neisseri by the use of a buffer containing a zwitterionic surface active agent, especially CHAPS or CHAPSO, in the absence of divalent cations. The extraction is conducted at elevated temperature, and provides a sample useful in assays for the presence of the bacteria.
    Type: Grant
    Filed: July 13, 1992
    Date of Patent: February 7, 1995
    Assignee: Unilever Patent Holdings B.V.
    Inventors: Ian W. Davidson, Paul Sheard